Morgan Stanley’s Artelo Biosciences, Inc. Warrant ARTLW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-162
| Closed | -$3 | – | 8004 |
|
|
2024
Q1 | $3 | Sell |
162
-162
| -50% | -$3 | ﹤0.01% | 7797 |
|
|
2023
Q4 | $12 | Buy |
324
+162
| +100% | +$5 | ﹤0.01% | 7776 |
|
|
2023
Q3 | $6 | Hold |
162
| – | – | ﹤0.01% | 7575 |
|
|
2023
Q2 | $8 | Hold |
162
| – | – | ﹤0.01% | 7613 |
|
|
2023
Q1 | $11 | Hold |
162
| – | – | ﹤0.01% | 7660 |
|
|
2022
Q4 | $6 | Hold |
162
| – | – | ﹤0.01% | 7828 |
|
|
2022
Q3 | $0 | Hold |
162
| – | – | ﹤0.01% | 7964 |
|
|
2022
Q2 | $0 | Hold |
162
| – | – | ﹤0.01% | 8070 |
|
|
2022
Q1 | $0 | Hold |
162
| – | – | ﹤0.01% | 8192 |
|
|
2021
Q4 | $0 | Hold |
162
| – | – | ﹤0.01% | 8171 |
|
|
2021
Q3 | $0 | Hold |
162
| – | – | ﹤0.01% | 8066 |
|
|
2021
Q2 | $0 | Hold |
162
| – | – | ﹤0.01% | 7833 |
|
|
2021
Q1 | $0 | Hold |
162
| – | – | ﹤0.01% | 7600 |
|
|
2020
Q4 | $0 | Hold |
162
| – | – | ﹤0.01% | 7146 |
|
|
2020
Q3 | $0 | Buy |
+162
| New | +$19 | ﹤0.01% | 6863 |
|
Morgan Stanley's ARTLW Position: Q2 2024 in Review
Morgan Stanley sold out of Artelo Biosciences, Inc. Warrant (ARTLW) in Q2 2024, closing a stake of 162 shares — an estimated $3 sold.
Morgan Stanley first reported a position in ARTLW in Q3 2020 and held it in 15 quarters. The position peaked at $12 in Q4 2023. 0 funds tracked by Wall St. Rank hold ARTLW as of Q2 2024.
- Morgan Stanley reported no remaining Artelo Biosciences, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
- Morgan Stanley sold 162 Artelo Biosciences, Inc. Warrant shares in Q2 2024, an estimated $3.
- Morgan Stanley first reported a position in Artelo Biosciences, Inc. Warrant in Q3 2020 and held it in 15 quarters.
- Morgan Stanley's Artelo Biosciences, Inc. Warrant position peaked at $12 in Q4 2023.
- 0 funds tracked by Wall St. Rank held Artelo Biosciences, Inc. Warrant as of Q2 2024.
Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.